4,5-diaminofluorescein diacetate,
4,5-diaminofluorescein-2 diacetate,
DAF-2DA,
DAF-2 DA,
4,5-Diaminofluorescein diacetate,
205391-02-2,
5,6-Diaminofluorescein diacetate,
DAF 2DA,
DAF-2 DA (cell permeable),
J-100023,
J-100116,
C24H18N2O7,
DAF-2DA,
AC1O7FZ6,
5,6-Diaminofluorescein diacetat,
SCHEMBL20520604,
CTK8E7129,
DTXSID70424951,
PTSUYDXEEKDBQU-UHFFFAOYSA-N,
HY-D0032,
1697AH,
MFCD05865101,
ZINC25783476,
AKOS025294862,
ACM205391022,
RT-012214,
CS-0009923,
4,5-Diaminofluorescein diacetate, >=98% (HPLC),
DAF-2 DA solution (5 mM in DMSO), 1 mg in 0.45 ml DMSO,
4,5-Diaminofluorescein diacetate/ 5,6-Diaminofluorescein diacetate,
(6'-acetyloxy-5,6-diamino-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate,
5,6-Diaminofluorescein diacetate, BioReagent, suitable for fluorescence, >=98.0% (HPLC),
Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-bis(acetyloxy)-5,6-diamino-,
Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,3',6'-bis(acetyloxy)-5,6-diamino-,
4,5-Diaminofluorescein diacetate-3',6'-bis(acetyloxy)-5,6-diamino-spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,
nchembio.92-comp6,
CID6603693,